
NANOREPRO AG
Share · DE0006577109 · 657710 (XFRA)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NANOREPRO AG
No Price
28.04.2026 10:46
Current Prices from NANOREPRO AG
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
XETRA |
NN6.DE
|
EUR
|
28.04.2026 10:46
|
1,54 EUR
| -0,01 EUR
-0,65 %
|
Quotrix |
NRAGIA09.DUSD
|
EUR
|
28.04.2026 05:27
|
1,52 EUR
| 0,01 EUR
+0,66 %
|
Düsseldorf |
NRAGIA09.DUSB
|
EUR
|
27.04.2026 17:31
|
1,50 EUR
| -0,01 EUR
-0,66 %
|
Hamburg |
NRAGIA09.HAMB
|
EUR
|
27.04.2026 06:16
|
1,47 EUR
| -0,04 EUR
-2,98 %
|
Company Profile for NANOREPRO AG Share
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.
Company Data
Name NANOREPRO AG
Company NanoRepro AG
Website
https://www.nanorepro.com
Primary Exchange
Frankfurt
Frankfurt
WKN 657710
ISIN DE0006577109
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Lisa Jungst
Market Capitalization 164 Mio
Country Germany
Currency EUR
Employees 0,0 T
Address Untergasse 8, 35037 Marburg
IPO Date 2021-03-02
Dividends from 'NANOREPRO AG'
| Ex-Date | Dividend per Share |
|---|---|
| 16.06.2023 | 0,15 EUR |
| 02.05.2022 | 0,50 EUR |
Stock Splits
| Date | Split |
|---|---|
| 04.12.2020 | 1019:1000 |
| 28.05.2018 | 1340:1311 |
| 06.03.2015 | 207:200 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | NNGRF |
| Düsseldorf | NRAGIA09.DUSB |
| Frankfurt | NN6.F |
| Hamburg | NRAGIA09.HAMB |
| Quotrix | NRAGIA09.DUSD |
| XETRA | NN6.DE |
More Shares
Investors who hold NANOREPRO AG also have the following shares in their portfolio:
